Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00287547
Status:
COMPLETED
Last Update Posted:
2011-04-25
First Post:
2006-02-06
Brief Title:
Phase II Randomized Double-Blind Placebo-Controlled Study of BMS-188667 CTLA4Ig in Patients With Psoriasis Vulgaris
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Psoriasis Vulgaris |
Keywords: